Spravato Treatment

Spravato is a prescription nasal spray containing esketamine — approved by the FDA in 2019 for treatment-resistant depression (TRD). Unlike traditional antidepressants that may take weeks, Spravato can produce improvement within hours to days. My Psychiatrist is a certified Spravato REMS treatment center.

Spravato is always administered under medical supervision at our office.

• Initial consultation to determine eligibility
• Weeks 1-4: Twice-weekly treatment sessions
• Weeks 5-8: Once-weekly treatment sessions
• Week 9+: Once weekly or every two weeks based on response
• Each session includes a 2-hour monitoring period
• Regular follow-ups to assess progress
• Coordination with your existing antidepressant regimen

Our psychiatrists give special attention to each patient, tailoring treatment based on history, family situation, and expectations. We manage medication judiciously to maximize efficacy while minimizing side effects.